Clorox Reports Q4 and FY24 Results, Provides FY25 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Clorox (CLX) PT Lowered to $140 at Evercore ISI
August 2, 2024 5:54 AM EDTEvercore ISI analyst Javier Escalante lowered the price target on Clorox (NYSE: CLX) to $140.00 (from $142.00) while maintaining a Underperform rating.
The analyst comments "Clorox beat this 4Q F24 on better gross margins, even as U.S. sales fell by 4% while consensus modeled flat. The controversy resides within Cloroxs most competitive household businesses,... More
Clorox (CLX) PT Raised to $148 at Jefferies
August 2, 2024 5:13 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on Clorox (NYSE: CLX) to $148.00 (from $147.00) while maintaining a Hold rating.
The analyst comments "Clorox's F4Q results were mixed (top-line missed / EPS great on high margin expansion), while its F25 EPS outlook was above... More
Clorox (CLX) Tops Q4 EPS by 27c, Offers Guidance
August 1, 2024 4:13 PM EDTClorox (NYSE: CLX) reported Q4 EPS of $1.82, $0.27 better than the analyst estimate of $1.55. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.95 billion.
GUIDANCE:
Clorox sees FY2025 EPS of $6.55-$6.80, versus the consensus of $6.45.
Net sales are expected to be flat to down 2% compared to the prior year. Organic sales are expected to be up... More